Clinical trial
Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple…
NCT00043264 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00043264 |
|---|---|
| Title | Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis |
| Official title | Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | National Multiple Sclerosis Society |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Rifampin, Azithromycin |
| Enrollment | 40 |
| First posted | Aug 8, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: